Report: North American cardiac and vascular x-ray market on the rise
The North American medical industry has experienced a rise in interventional procedural volumes, which has driven the growth of the cardiovascular x-ray equipment market, according to a new report by the market research firm Frost & Sullivan.
Frost & Sullivan found that the North American cardiac and vascular x-ray equipment markets earned revenues of $765.4 million in 2006, and estimates that the revenues will reach $894.4 million in 2013.
“New and innovative technological advancements make it possible to thoroughly examine patients of all sizes, improving both workflow and diagnostic confidence for clinicians,” according to Samantha Barbosa, Frost & Sullivan research analyst. "Strong procedural growth within the market will continue to drive the market, helping offset the competition posed by other imaging modalities.”
Given the constant possibility of reimbursement cuts, it is important for clinicians to focus on the interventional side, according to the report. The firm said that as a result, vendors should continue to be innovative and supply clinicians with interoperable systems similar to those in the multipurpose labs.
“X-ray medical imaging is overcoming the battle against proposed cuts in imaging reimbursement in addition to being a competitive choice in medical diagnostics,” Barbosa said. “Advancements in 3D imaging and enhancements to the multipurpose lab will also help the cardiovascular x-ray market stay abreast of the competition.”
Frost & Sullivan found that the North American cardiac and vascular x-ray equipment markets earned revenues of $765.4 million in 2006, and estimates that the revenues will reach $894.4 million in 2013.
“New and innovative technological advancements make it possible to thoroughly examine patients of all sizes, improving both workflow and diagnostic confidence for clinicians,” according to Samantha Barbosa, Frost & Sullivan research analyst. "Strong procedural growth within the market will continue to drive the market, helping offset the competition posed by other imaging modalities.”
Given the constant possibility of reimbursement cuts, it is important for clinicians to focus on the interventional side, according to the report. The firm said that as a result, vendors should continue to be innovative and supply clinicians with interoperable systems similar to those in the multipurpose labs.
“X-ray medical imaging is overcoming the battle against proposed cuts in imaging reimbursement in addition to being a competitive choice in medical diagnostics,” Barbosa said. “Advancements in 3D imaging and enhancements to the multipurpose lab will also help the cardiovascular x-ray market stay abreast of the competition.”